Study wrapper · #190
The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.
Editor's note
A controlled animal study in Mozambique tilapia examining how the ghrelin-receptor agonist ipamorelin acetate affects the reproductive (hypothalamic-pituitary-testicular) axis in fish. This is basic comparative-physiology research at the preclinical tier, and a distant one: findings in a cichlid fish speak to conserved endocrine biology, not to human or even mammalian outcomes, and should not be read across to people. Researchers reported that 21 days of ipamorelin at 5 or 30 micrograms produced a dose-dependent rise in food intake alongside increased numbers of developing sperm cells (spermatocytes and spermatids), with the higher dose also raising serum luteinising hormone and 11-ketotestosterone and increasing testicular androgen-receptor expression, while hypothalamic and pituitary GnRH-immunoreactive fibres were unchanged. The authors interpret this as ghrelin-signalling enhancement of germ-cell development mediated through androgen and LH pathways at the testis. For our audience the value is purely mechanistic. These are preclinical findings in a fish model; human data are needed before clinical conclusions can be drawn.
Plain-language abstract
This was a laboratory study in tilapia, a type of fish, looking at how ipamorelin, a peptide that activates the ghrelin receptor, affects the reproductive system. Ghrelin is a hormone found in the brain and gut that helps control several body systems. Researchers gave male fish either 5 or 30 micrograms of ipamorelin for 21 days and compared them with untreated fish. Both doses increased food intake and raised the numbers of developing sperm cells. The higher dose also increased late-stage sperm cells and enlarged parts of the sperm-producing structures, raised blood levels of luteinising hormone and the fish male hormone 11-ketotestosterone, and increased androgen (male-hormone) receptor levels in the testes. The amount of gonadotropin-releasing hormone signalling in the brain and pituitary did not change. The authors concluded that boosting ghrelin signalling encouraged sperm-cell development, probably by acting through male-hormone and luteinising-hormone pathways at the testis and pituitary. This is early research in fish; it does not tell us about effects in people, and human studies would be needed before drawing any conclusions.